Kevin Duan, MD

TitleAssistant Clinical Professor
InstitutionUniversity of California San Francisco
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Makaroun LK, Bowman C, Duan K, Handley N, Wheeler DJ, Pierluissi E, Chen AH. Specialty Care Access in the Safety Net-the Role of Public Hospitals and Health Systems. J Health Care Poor Underserved. 2017; 28(1):566-581. PMID: 28239019.
      View in: PubMed
    2. Duan K, Sheu L. Behind closed doors. Med Teach. 2017 May; 39(5):558-559. PMID: 27924665.
      View in: PubMed
    3. Korenstein D, Duan K, Diaz MJ, Ahn R, Keyhani S. Do Health Care Delivery System Reforms Improve Value? The Jury Is Still Out. Med Care. 2016 Jan; 54(1):55-66. PMID: 26492216; PMCID: PMC4869989.
    4. de la Monte SM, Pang M, Chaudhry R, Duan K, Longato L, Carter J, Ouh J, Wands JR. Peroxisome proliferator-activated receptor agonist treatment of alcohol-induced hepatic insulin resistance. Hepatol Res. 2011 Apr; 41(4):386-98. PMID: 21426453; PMCID: PMC3399907.
    5. Duan KI, Englesbe MJ, Volk ML. Centers for Disease Control 'high-risk' donors and kidney utilization. Am J Transplant. 2010 Feb; 10(2):416-20. PMID: 19958324.
      View in: PubMed
    6. Pang M, de la Monte SM, Longato L, Tong M, He J, Chaudhry R, Duan K, Ouh J, Wands JR. PPARdelta agonist attenuates alcohol-induced hepatic insulin resistance and improves liver injury and repair. J Hepatol. 2009 Jun; 50(6):1192-201. PMID: 19398227; PMCID: PMC2680444.
    7. de la Monte SM, Yeon JE, Tong M, Longato L, Chaudhry R, Pang MY, Duan K, Wands JR. Insulin resistance in experimental alcohol-induced liver disease. J Gastroenterol Hepatol. 2008 Aug; 23(8 Pt 2):e477-86. PMID: 18505416.
      View in: PubMed